Expert Analysis

How 11th Circ.'s Zafirov Decision Could Upend Qui Tam Cases

Oral argument before the Eleventh Circuit last month in U.S. ex rel. Zafirov v. Florida Medical Associates suggest... (more story)

Key Trends For Life Sciences Cos. To Watch In 2026

Following a year of drastic change at the U.S. Food and Drug Administration, two themes are likely to drive the co... (more story)

The Next Pressure Point In Digital Health: Informed Consent

Two new federal digital health initiatives will usher in a new era where virtual care, software-enabled devices an... (more story)

Deals & Corporate Governance More

Ex-Doximity Exec Cops To $2.5M Insider Trading Scheme

The former chief revenue officer of publicly traded medical professional networking platform Doximity pled guilty Friday in New York federal court to securities fraud in connection to allegations that he illeg... (more story)

Biopharma Co. Secures D&O Coverage For Shareholder Suit

A biopharmaceutical company is entitled to coverage for a suit alleging its board breached fiduciary duties under a pair of primary and excess directors and officers policies, a Delaware state court ruled, say... (more story)

Judge Blocks Edwards' $945M Heart Valve Deal

A D.C. federal judge issued an order on Friday preventing Edwards Lifesciences Corp. from moving ahead with its planned $945 million deal for JenaValve Technology Inc., torpedoing the merger challenged by the ... (more story)

NC Biz Court Bulletin: Trade Secrets Row, A Patient Data Deal

The North Carolina Business Court closed out the year by tossing a trade secrets fight brought by a corrugated packing manufacturer against its onetime star salesman and signing off on a $2.45 million settleme... (more story)

Ardent Health Investors Sue Over Revenue Accounting Issues

Tennessee-based healthcare provider Ardent Health Inc. was hit with a proposed shareholder class action accusing it of misleading investors about the collectability of accounts receivable and the sufficiency o... (more story)

FTC Battles Edwards On Eve Of Heart Valve Merger Deadline

The Federal Trade Commission asked a D.C. federal judge for a last-minute extension on an order blocking Edwards Lifesciences' $945 million acquisition of JenaValve Technology Inc., fearing difficulty with uns... (more story)

Digital Health & Technology More

9th Circ. Revives Suit Over Milliman's 'Fuzzy Matching' Tactic

The Ninth Circuit on Friday reversed a decision tossing one of two classes in litigation accusing consulting firm Milliman of peddling inaccurate information by using a strategy known as "fuzzy" data matching ... (more story)

Wash. Justices Take Up Pixel Privacy Suit Against Hospital

The Washington Supreme Court has taken up a group of parents' bid to revive their proposed class action accusing Seattle Children's Hospital of sharing their private data with Facebook parent company Meta by i... (more story)

Cooley-Led Eir Partners Wraps $1B Health Tech Fund

Cooley LLP-advised private equity shop Eir Partners Capital LP on Thursday announced that it wrapped its third fund with $1 billion of investor commitments, which will be used to invest in health technology an... (more story)

Biotech Co. Says HHS Infringed Patent With Moderna Vax Deal

A biotech company that developed a patented protein technology that allegedly expedited the development of Moderna's COVID-19 Spikevax vaccine sued the U.S. Department of Health and Human Services on Wednesday... (more story)

4 Trends Shaping Drug And Medical Device Law For 2026

2025 saw some significant legal developments with potential impact for drug and device manufacturers, ranging from growing skepticism in science and regulatory entities to new regulation of artificial intellig... (more story)

DOJ's Wound Care 'Glam-Flam' Case: What You Need To Know

A first-of-its-kind fraud involving wound care that used human placental tissue led to prison sentences for an Arizona wife and husband known as the "glam-flam" couple, as well as a nearly $310 million settlem... (more story)

Policy & Compliance More

Mylan, Aurobindo Must Face Generic Drug Price-Fixing Claims

A Connecticut federal judge on Friday refused to hand a quick win to Mylan Pharmaceuticals and Aurobindo Pharma USA in sprawling antitrust litigation against 26 total pharmaceutical companies, ruling that a co... (more story)

Up Next At High Court: Pollution Lawsuits & Trans Athletes

The U.S. Supreme Court will kick off the new year by hearing disputes over the constitutionality of state laws banning transgender female athletes from female-only sports and whether state or federal courts ar... (more story)

Mich. Bid For Behavioral Managed Care Contracts Can't Stand

A Michigan Court of Claims judge ruled the state health department's bid for Medicaid managed care contract proposals would unlawfully interfere with the duties of local governmental bodies that provide and co... (more story)

Veterinary Group Says DOJ Accreditation Points Irrelevant

The American Veterinary Medical Association has told a Tennessee federal court that the government's concerns about professional groups are irrelevant to a veterinary school's antitrust case challenging the as... (more story)

Ex-Prosecutor OK For Drug Pricing MDL, Special Master Says

Former Connecticut Assistant Attorney General Joseph Nielsen and his law firm, Lowey Dannenberg PC, should not be disqualified from representing insurers in multidistrict litigation over generic drug price-fix... (more story)

Walgreens Gets $392K Sanction Against Blue Cross Insurers

A Chicago federal judge on Thursday ordered a host of Blue Cross Blue Shield insurers to pay Walgreens more than $392,000 in attorney fees and expenses for discovery misconduct in their suit that accuses the d... (more story)